Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinoma identifies potential novel therapeutic options

Authors:

Ghassan K. Abou-Alfa1, John T. Miura, T. Clark Gamblin, Joanne Xiu, Sherri Z. Millis, Zoran Gatalica, Sandeep K. Reddy, Celina Ang, Nelson S. Yee

Background

Effective treatment strategies for hepatocellular carcinoma (HCC) remain limited. Identification of additional therapies remains paramount as currently available agents have resulted in marginal improvements in overall survival.

Download Publication